Heidi Hagen - Director at Alaunos Therapeutics, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
TCRT on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Heidi Hagen since 28 Sep 2025

Reported holdings for Heidi Hagen in Alaunos Therapeutics, Inc.

Form 4 holding Director

ZIOPHARM ONCOLOGY INC

Security class
Common Stock
Shares / value
145,889
Estimated value
$20,468
Report date
02 Sep 2021
Price
$0.1403
Ownership
Direct

Transaction history for Heidi Hagen in Alaunos Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .